Feline Health, a tech-enabled preventative health startup, has raised $700 million with backing from celebrities Claudia Schiffer, Maria Sharapova, Mark Zuckerberg and Priscilla Chan, among others, and has entered the U.S. market with plans to open a clinic in New York City later this year.
The company, founded by Spotify founders and former CEOs Daniel Ek and Hjalmar Nilssonne, offers non-invasive, radiation-free diagnostic scans that can capture millions of health data points. Unlike competitors Prenuvo and Ezra, which are currently owned by Function Health, Neko Health does not use large medical imaging machines such as MRIs for its scans.
Neo Health collects data about an individual’s skin, heart, blood, and metabolic health. The scan uses proprietary sensors alongside blood analysis to assess skin health conditions such as moles and marks, biomarkers to identify pre-diabetic risk, blood abnormalities, and risk factors associated with metabolic syndrome, stroke, and heart attack. Customers receive results on the spot and have the ability to meet directly with a medical professional to discuss the results.
Neko Health scanning technology
Neo Health offers a 60-minute radiation-free health exam (Neko Health)
Neo has upgraded its health scan and added wearable integration and body composition analysis.
The scan costs £299 in the UK, or approximately $341 in US dollars based on current exchange rates. The company did not disclose scanning costs in the U.S. market.
Lightspeed Venture Partners and OG Venture Partners co-led the Series C round, with participation from existing investors Atomico, General Catalyst, and Lakestar, as well as new backers including Liberty City Ventures, Positive Sum, and BDT & MSD. As part of this round, David Offerer of OG Venture Partners will join the company’s board of directors.
Ari Emanuel, Sir Matthew Vaughan, Danny Meyer, Jimmy Iovine, Thierry Henry, Tim Ferriss and will.i.am also participated in the funding round, joining existing investors including 77Six’s Alexis Ohanian, Calm’s Alex Tew, Michael Acton-Smith, Gary Vaynerchuk, Jesse Inshauspe, Katie Horne, Raj Shyamani, Stephen Bartlett and Zoe. Saldaña and Marco Perego Saldaña.
The company has not disclosed the valuation.
Neo Health raised $260 million in Series B funding in January 2025.
“This funding is a strong vote of confidence in what we set out to do when we opened our first clinic three years ago: an entirely new healthcare experience designed to help people stay healthy, catch problems early and prevent disease before it starts,” said Nilssonne, CEO of Neko Health, in a statement. “With this round, we are bringing that mission to the United States for the first time while continuing to invest in research and technology that enables prevention at scale. The clearest evidence is in our members. The vast majority of our members return after their first scan, and when they return, their health markers move in the right direction.”
Founded in 2023, the company operates clinics in Sweden and the UK, including multiple locations in Manchester, Birmingham and London. The company says more than 350,000 people have joined the waiting list or registered for a test, and more than 100,000 members have already been tested. According to Neo Health, on average 75% of members book and prepay for next year’s scan at the end of their appointment.
Neo Health says it builds its technology in-house, including hardware, software and consumer experience. Executives say this allows companies to control the experience from start to finish, move faster, and continually improve.
Last month, Neko opened its newest clinic in Stockholm. The clinic is built around Neko-designed next-generation medical devices, Derma-2, Echo-2, and Spectrum-2, each of which has been upgraded to capture greater volume and higher fidelity of health signals across the skin, heart, and circulation. This next-generation hardware will be rolled out to all cat clinics in the coming months.
The company plans to use the funds to accelerate growth in the U.S. and invest in technology.
“Over the past 18 months, Neko Health has demonstrated remarkable innovation and growth, leveraging breakthrough technology, proven consumer demand, and global reach,” said Bejul Somaia, Global Partner at Lightspeed Venture Partners. We believe they are one of the most important healthcare companies of our generation and are proud to deepen our partnership with them as they continue to reimagine prevention.”
Selective, direct-to-consumer full body scans are a growing market driven by advances in artificial intelligence that speed up scanning. According to data from SNS Insider, the market was valued at $29.7 billion in 2025 and is projected to reach $47.2 billion by 2033.
Major players in the market include Prenuvo, Ezra, which has merged with Function Health, and SimonMed. Prenuvo raised $120 million in 2025 and currently operates 29 clinics primarily in the United States, with three clinics in Vancouver, Canada, London, and Melbourne, Australia.
Function Health, a preventive health and longevity startup, acquired Ezra in May 2025 to integrate Function’s clinical testing capabilities with the company’s AI-powered full body scanning. The company raised $300 million in a Series B round in November.
